Drug discovery at Charles River delivers world-class science.
Every complex discovery program faces a unique set of challenges. Whether it's a resource gap, time constraint, or an unexpected result, navigating around potential pitfalls is essential for advancing your program successfully. Charles River is industry-proven in successfully identifying and assessing novel therapies, with over 320 patents and 75 preclinical drug development candidates delivered to our sponsors since 2001. Backed by more than 650 scientists, our comprehensive, integrated portfolio employs the latest technology and platforms to provide chemistry, biology, and pharmacology services that support clients from the earliest stages of hit identification all the way through to IND.
